Zobrazeno 1 - 10
of 165
pro vyhledávání: '"Hiroyuki Tani"'
Publikováno v:
BMC Veterinary Research, Vol 18, Iss 1, Pp 1-6 (2022)
Abstract Background Multiple myeloma (MM) is an uncommon neoplasm in cats. There is no established standard of treatment due to the rare occurrence of this disease in cats. Bortezomib is a proteasome inhibitor that serves as the first-line drug for M
Externí odkaz:
https://doaj.org/article/31c85972294e46d6b3555035cc456e31
Autor:
Kosei Sakai, Shingo Hatoya, Masaru Furuya, Tomoyo Nabetani, Ryoji Kanegi, Shunsuke Shimamura, Hiroyuki Tani, Terumasa Shimada
Publikováno v:
Veterinary Medicine and Science, Vol 8, Iss 1, Pp 3-8 (2022)
Abstract Background Nimustine, similar to lomustine, is an alkylating agent from the nitrosourea family. There have been some reports regarding lomustine treatment for tumour‐bearing cats. However, information regarding nimustine treatment for tumo
Externí odkaz:
https://doaj.org/article/ac3898cd5e5344d2ac99832e4f45f6a1
Autor:
Hiroyuki Tani, Ryo Miyamoto, Syunya Noguchi, Sena Kurita, Tomokazu Nagashima, Masaki Michishita, Naoko Yayoshi, Kyoichi Tamura, Makoto Bonkobara
Publikováno v:
BMC Veterinary Research, Vol 17, Iss 1, Pp 1-7 (2021)
Abstract Background Canine malignant melanoma is highly aggressive and generally chemoresistant. Toceranib is a kinase inhibitor drug that inhibits several tyrosine kinases including the proto-oncogene receptor tyrosine kinase KIT. Although canine ma
Externí odkaz:
https://doaj.org/article/72bcb6d775514e2fb1f6c607fec8f79b
Autor:
Mayo Yasugi, Shingo Hatoya, Daisuke Motooka, Yuki Matsumoto, Shunsuke Shimamura, Hiroyuki Tani, Masaru Furuya, Keiichiro Mie, Masami Miyake, Shota Nakamura, Terumasa Shimada
Publikováno v:
PLoS ONE, Vol 16, Iss 2, p e0246482 (2021)
The emergence and global spread of extended-spectrum or AmpC β-lactamase (ESBL/AmpC)-producing Enterobacteriaceae in companion animals have led to the hypothesis that companion animals might be reservoirs for cross-species transmission because of th
Externí odkaz:
https://doaj.org/article/0114d53628d840e4b61b715c80d9aadd
Publikováno v:
Internal Medicine; 2024, Vol. 63 Issue 11, p1585-1590, 6p
Publikováno v:
Journal of Comparative Pathology. 203:19-22
Autor:
Yuki Tanaka, Hikaru Hamase, Kazuki Kanai, Ryosuke Hasaba, Hiroshi Sato, Yoshio Koyanagi, Takuma Ikeda, Hiroyuki Tani, Manabu Gokan, Shoichi Kajiwara, Naoki Shinohara
Publikováno v:
IEEE Transactions on Microwave Theory and Techniques. 71:102-111
Autor:
Kosei SAKAI, Tomoki MOTEGI, James Ken CHAMBERS, Kazuyuki UCHIDA, Hidetaka NISHIDA, Shunsuke SHIMAMURA, Hiroyuki TANI, Terumasa SHIMADA, Masaru FURUYA
Publikováno v:
Journal of Veterinary Medical Science. 84:502-506
Autor:
Masaru Furuya, Kosei Sakai, Hiroyuki Tani, Shunsuke Shimamura, Terumasa Shimada, Tomoyo Nabetani, Ryoji Kanegi, Shingo Hatoya
Publikováno v:
Veterinary Medicine and Science, Vol 8, Iss 1, Pp 3-8 (2022)
Veterinary Medicine and Science
Veterinary Medicine and Science
Background Nimustine, similar to lomustine, is an alkylating agent from the nitrosourea family. There have been some reports regarding lomustine treatment for tumour‐bearing cats. However, information regarding nimustine treatment for tumour‐bear
Autor:
Masaki Michishita, Ryo Miyamoto, Kyoichi Tamura, Tomokazu Nagashima, Hiroyuki Tani, Makoto Bonkobara
Publikováno v:
Veterinary and Comparative Oncology. 20:109-117
Canine histiocytic sarcoma (HS) is an aggressive and highly metastatic neoplasm. Mutations in src homology 2 domain-containing phosphatase 2 (SHP2; encoded by PTPN11), which recently have been identified in canine HS tumour cells, could be attractive